NRx Pharmaceuticals, Inc. (NRXP) Reports Q2 Loss, Misses Revenue Estimates
Yahoo Finance · Aug 15, 2026 · Phreesia Inc (PHR)
NRx Pharmaceuticals (NRXP) delivered earnings and revenue surprises of -100.00% and -54.13%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Not investment advice. Cached headline, not a full reprint.